Permit the Filing of an Abbreviated New Animal Drug Application for (Marbofloxacin) Chewable Tablet Formulation in Strengths of 25 mg, 50 mg, 100 mg and 200 mg - CLOSED

 
Docket ID: FDA-2011-P-0335
Agency: Food and Drug Administration (FDA)
Parent Agency: Department of Health and Human Services (HHS)
Summary:
Status: CLOSED Closed per letter of 7;22/11
Docket Details open glossary dialog  
Related RINs: None
Related Dockets: None
Short Title: Permit the Filing of an Abbreviated New Animal Drug Application for (Marbofloxacin) Chewable Tablet Formulation in Strengths of 25 mg, 50 mg, 100 mg and 200 mg
Keyword(s): Zeniquin Tablets, Marbofloxacin, ANADA, CDER, CLOSED
Type: Nonrulemaking
Docket Status: CLOSED
Center: CVM
Docket Item Code: P
 

Primary Documents

View All  (4)
Comment Period Closed
Other
Posted: 08/04/2011
ID: FDA-2011-P-0335-0004
Comment Period Closed
Other
Posted: 06/30/2011
ID: FDA-2011-P-0335-0003
Comment Period Closed
Other
Posted: 05/16/2011
ID: FDA-2011-P-0335-0002
Comment Period Closed
Other
Posted: 05/16/2011
ID: FDA-2011-P-0335-0001

Supporting Documents

 
No documents available.

Comments

 
No comments posted.

0
Comments Received*
*This count refers to the total comment/submissions received on this docket, as of 11:59 PM yesterday. Note: Agencies review all submissions, however some agencies may choose to redact, or withhold, certain submissions (or portions thereof) such as those containing private or proprietary information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. This can result in discrepancies between this count and those displayed when conducting searches on the Public Submission document type. For specific information about an agency’s public submission policy, refer to its website or the Federal Register document.